Psilocybin has better response than placebo in antidepressant trials
By
Haymarket Media
Aug 28, 2024
Only high-dose psilocybin was better than placebo in antidepressant trials of escitalopram.
Extended-release oral ketamine effective for treatment-resistant depression
Jul 17, 2024
Excellent tolerability was seen, with no changes in blood pressure, minimal reports of sedation and minimal dissociation.
New report calls for more research on women’s health issues
Jul 12, 2024
The National Academies of Sciences, Engineering and Medicine analysis noted that women are disproportionately affected by chronic illnesses, including Alzheimer’s disease, depression and osteoporosis.
Some environmental toxicants linked to depressive symptoms
Jul 09, 2024
Six of 10 categories of environmental toxicants were linked to the prevalence of depressive symptoms.